Generic Name: fingolimod (fin GOE li mod)
Brand Names: Gilenya
Medically reviewed by Philip Thornton, DipPharm. Last updated on Feb 3, 2020.
What is Gilenya?
Gilenya is used to treat relapsing multiple sclerosis (MS) in adults, and children and adolescents aged 10 years and older.
Gilenya will not cure MS, it will only decrease the frequency of relapse symptoms.
You should not use Gilenya if you have a serious heart condition. This includes severe heart failure, "AV block," sick sinus syndrome (unless you have a pacemaker), taking certain heart rhythm medicines, or a recent heart attack, stroke, chest pain, or other serious heart problem.
Fingolimod can slow your heart rate. You will receive your first dose in a hospital setting where your heart rhythm can be monitored.
Gilenya affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, aches, tiredness, vomiting, confusion, neck stiffness, increased sensitivity to light, or problems with speech, thought, vision, or muscle movement.
Before taking this medicine
You should not use Gilenya if you are allergic to fingolimod, or if you have certain serious heart conditions, especially:
severe heart failure (that required you to be in the hospital);
"AV block" or sick sinus syndrome (unless you have a pacemaker);
long QT syndrome; or
recent (within the past 6 months) heart attack, stroke, "mini-stroke" or TIA, chest pain (unstable angina), or other serious heart problem.
Some heart rhythm medications can cause unwanted or dangerous effects when used with fingolimod. Your doctor may change your treatment plan if you also use: amiodarone, disopyramide, dofetilide, flecainide, dronedarone, ibutilide, mexiletine, procainamide, propafenone, quinidine, or sotalol.
Before you take Gilenya, tell your doctor if you have never had chickenpox or if you have never received a varicella vaccine (Varivax). You may need to receive the vaccine and then wait 1 month before taking this medicine.
Tell your doctor if you have ever had:
an active or chronic infection;
a heart rhythm disorder;
chest pain (angina) or other heart problems;
a heart attack or stroke, including "mini-stroke";
high or low blood pressure;
an eye condition called uveitis; or
Using Gilenya may increase your risk of developing skin cancer (melanoma). Ask your doctor about skin symptoms to watch for.
Fingolimod may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine, and for at least 2 months after your last dose. Tell your doctor if you become pregnant during this time.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of fingolimod on the baby.
It may not be safe to breastfeed while using fingolimod. Ask your doctor about any risk.
How should I take Gilenya?
Take Gilenya exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.
Your doctor will perform medical tests to make sure you do not have conditions that would prevent you from safely using Gilenya.
Fingolimod can slow your heart rate. You will receive your first dose in a hospital setting. Your blood pressure and heart rate will be constantly monitored for at least 6 hours after your first dose of Gilenya.
You may take Gilenya with or without food.
If you stop taking Gilenya, do not start taking it again without asking your doctor. You will need to be under medical observation when you restart this medication
Always ask your doctor before you stop taking Gilenya for any reason. When you stop taking this medicine, your MS symptoms may return. In rare cases, some people who stopped taking fingolimod had MS symptoms that were worse than before or during treatment with this medicine.
If you stop taking Gilenya, watch for signs of worsening MS for at least 12 weeks after your last dose. Call your doctor right away if any new or worsening symptoms appear.
Gilenya affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis. Your risk of infection could last up to 2 months after you stop taking this medicine.
Store in the original package at room temperature away from moisture and heat.
Gilenya dosing information
Usual Adult Dose for Multiple Sclerosis:
0.5 mg orally once daily
Comments: Monitor with first dose (see WARNINGS section).
Use: For the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.
What happens if I miss a dose?
Call your doctor for instructions. If you miss 1 or more doses, you may need to take your next dose under medical observation in a medical setting.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking Gilenya?
Gilenya can increase your risk of skin cancer. Avoid sunlight or tanning beds. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.
Do not receive a "live" vaccine while using fingolimod, and for 2 months after your last dose. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), or zoster (shingles).
Gilenya side effects
Get emergency medical help if you have signs of an allergic reaction to Gilenya: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Fingolimod may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement. These symptoms may start gradually and get worse quickly.
Also call your doctor at once if you have:
shiny nodules on your skin, sores that do not heal, unusual moles that change in color or size;
blurred vision, eye pain, or a blind spot or shadows in the center of your vision (may occur 3 to 4 months after you start taking fingolimod);
new or worsened breathing problems;
sores in your mouth and throat, cold sores, sores on your genital or anal area;
blood vessel problems in the brain - headache, confusion, change in mental status, sudden vision loss, seizure (convulsions);
heart problems - chest pain, slow or irregular heartbeats, and feeling dizzy or tired;
liver problems -nausea, upper stomach pain, tiredness, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes); or
signs of infection - fever, chills, body aches, tiredness, nausea and vomiting, neck stiffness, increased sensitivity to light.
Common Gilenya side effects may include:
headache, back pain;
stomach pain, diarrhea;
pain in your arms or legs;
cough, stuffy nose, flu symptoms; or
abnormal liver function tests.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect Gilenya?
Gilenya can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.
Tell your doctor about all the other medicines you take, especially:
drugs that weaken the immune system such as cancer medicine, steroids, and medicines to prevent organ transplant rejection.
Many drugs can interact with fingolimod. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Gilenya only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2020 Cerner Multum, Inc. Version: 7.01.
Gilenya and Tecfidera are both disease-modifying oral medications approved for the treatment of MS. Both are equally effective although Tecfidera is more likely than Gilenya to be discontinued within 24 months. Gilenya is approved to treat adults and children aged 10 and older and Tecfidera is only approved for adults over the age of 18. Common side effects of Gilenya include heart rhythm disturbances, diarrhea, infections, and elevations in liver enzymes and common side effects of Tecfidera include flushing, gastrointestinal disturbances, and infections. Tecfidera is slightly more expensive than Gilenya. Read more
- What are the new drugs used for multiple sclerosis (MS)?
- What happens when you stop taking Gilenya?
- How long does it take Gilenya to work?
- Does Gilenya cause hair loss?
- Does Gilenya suppress the immune system?
- Where is Gilenya manufactured and by whom?
- How much does Gilenya cost?
- What does Gilenya do for multiple sclerosis (MS)?
More about Gilenya (fingolimod)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 88 Reviews
- Generic Availability
- Drug class: selective immunosuppressants
- FDA Alerts (5)
- FDA Approval History